Navigation Links
Blood test identifies people at risk for heart attack that other tests miss
Date:4/19/2010

within the field of cardiology for this test," Farrell says. "The gamma-prime fibrinogen test would be used in conjunction with a cholesterol test to better predict who is likely to suffer a heart attack. Ultimately we are optimistic we can identify people who are at risk who didn't know they are at risk."

OHSU has filed a provisional patent application for a gamma-prime fibrinogen test. Farrell and his colleagues also have formed a company called Gamma Therapeutics, Inc. to mass-produce the assay. OHSU has a process in place to review and manage the individual and institutional conflicts of interest that may arise through its start-up companies.

The gamma-prime fibrinogen research was sponsored by the National Heart, Lung and Blood Institute of the National Institutes of Health.


'/>"/>

Contact: Ken Olsen
olsenke@ohsu.edu
503-494-8231
Oregon Health & Science University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Blood stem-cell transplant regimen reverses sickle cell disease in adults
2. Blood Thinner Combos Risky for Heart Attack Patients
3. China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009
4. A better sign of blood vessel narrowing and early coronary artery disease
5. American Red Cross and Other U.S. Blood Centers Send Blood to Haiti
6. Analysis Examines Ultrasound Use for Blood Clots
7. Minnesota Vikings Team With Memorial Blood Centers Again for Annual Blood Drive
8. Newly discovered mechanism by which blood clots form
9. Long Before Symptoms, Blood May Reveal Rheumatoid Arthritis
10. Fat Tissue May Be a Source of Valuable Blood Stem Cells, Study Says
11. Hematologists Can Now Earn CME Credits Through the Journal Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... World Patent ... and Found, a breakthrough technological invention. It is a wearable personal tracking ... electronic industry reached a record high of $211.3 billion in 2014," says Scott ...
(Date:7/28/2015)... NJ (PRWEB) , ... July 28, 2015 , ... Morristown ... in New Jersey, and one of the first five hospitals in the nation, to ... in three patients on July 23, and all are in good condition. , The ...
(Date:7/28/2015)... ... July 28, 2015 , ... DuPont ... visit to Ethiopia to learn more about the impact of U.S. collaborations with ... initiative focuses on accelerating agricultural development as an engine of broad-based economic growth ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Women in ... Washington, D.C. technology community for over 20 years, has selected Lisa Dezzutti, CEO and ... upcoming year. , “I am excited to serve this organization that empowers women to ...
(Date:7/28/2015)... ... July 28, 2015 , ... OrthAlign, Inc., a ... ORTHALIGN PLUS® system, a palm-sized, single-use navigation device for Total Hip Arthroplasty (cup ... with practicality in a revolutionary way for Total Knee Arthroplasty surgeries and is ...
Breaking Medicine News(10 mins):Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 4Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 5Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 3
... Behen HealthDay Reporter , WEDNESDAY, Sept. 22 ... arthritis (RA) may benefit patients with this chronic autoimmune ... therapy, researchers say. The oral medication, known as ... of drugs known as spleen tyrosine kinase (Syk) inhibitors, ...
... The American Society for Radiation Oncology (ASTRO) is pleased ... Recipients will receive their honors during ASTRO,s 52nd Annual ... 2010. ,"It is my pleasure to congratulate each ... this year," Anthony L. Zietman, M.D., ASTRO president and ...
... international study of patients with a devastating type of dementia ... evidence that career choice may influence where the disease takes ... led by Baycrest,s Rotman Research Institute in collaboration with the ... Francisco and several U.S. and European clinical sites. It appears ...
... HealthDay Reporter , TUESDAY, Sept. 21 (HealthDay News) -- ... 3-D movies, everyone seems to be oohing and ahhing over ... Well, almost everyone. "There will be at least one ... about? I didn,t see anything flying out at me., Or ...
... finds that college women with roommates who weigh more ... than women with slimmer roommates: half a pound versus ... freshman weight gain of 2.5-to-6 pounds---much less than the ... there are some good explanations for why it may ...
... PROVIDENCE, RI Damian Dupuy, MD, of Rhode Island ... from the American College of Radiology Imaging Network (ACRIN). ... on the use of radiofrequency ablation (RFA) to reduce ... the bone). The award recognizes a scientific paper published ...
Cached Medicine News:Health News:Novel Rheumatoid Arthritis Drug Shows Early Promise 2Health News:Novel Rheumatoid Arthritis Drug Shows Early Promise 3Health News:Novel Rheumatoid Arthritis Drug Shows Early Promise 4Health News:ASTRO announces 2010 Annual Meeting awards 2Health News:ASTRO announces 2010 Annual Meeting awards 3Health News:For sufferers of an early-onset dementia, career choice may determine location of disease in brain 2Health News:For sufferers of an early-onset dementia, career choice may determine location of disease in brain 3Health News:Vision Problems Can Rob Movie-Goers of 3-D 2Health News:Vision Problems Can Rob Movie-Goers of 3-D 3Health News:Freshman weight gain: Women with heavy roommates gain less 2Health News:Rhode Island Hospital physician receives national award for research 2
(Date:7/28/2015)... July 28, 2015 Voalte, the leader ... leader in purpose-built wireless communications, today announced that ... a 104-bed acute-care facility in Webster, ... Voalte One™ solution on Spectralink PIVOT™ purpose-built smartphones ... named Voalte a member of its AIMS Partner ...
(Date:7/28/2015)... 2015 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ... its second quarter and year-to-date 2015 financial results on ... U.S. financial markets. The earnings press release will be ... website, www.anipharmaceuticals.com . Arthur S. ... Charlotte C. Arnold , Vice President and Chief Financial ...
(Date:7/28/2015)... July 21, 2015 Research and Markets ... the "Pharmaceutical Industry in China to 2020: ... Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, ... offering. This report tackles not ... China but also home grown companies ...
Breaking Medicine Technology:Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 2Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 3ANI Pharmaceuticals Schedules Conference Call for Second Quarter and Year-to-Date 2015 Financial Results 2Pharmaceutical Industry in China to 2020: Market to Increase Dramatically to $200 Billion 2
... Feb. 16, 2012 OPKO Health, Inc. and ChromaDex ... a strategic alliance pursuant to which ChromaDex has licensed ... health care technologies for distribution and business development throughout ... commercialized are BluScience™ ( www.bluscience.com ), ChromaDex,s ...
... Food and Drug Administration (FDA) has recently issued alerts ... including , hair regrowth products that may ... over-the-counter medications that may contain the wrong tablets in ... cosmetics that contain an anesthetic drug ingredient and harmful ...
Cached Medicine Technology:OPKO Health, Inc. Invests in ChromaDex® Corp. 2OPKO Health, Inc. Invests in ChromaDex® Corp. 3OPKO Health, Inc. Invests in ChromaDex® Corp. 4OPKO Health, Inc. Invests in ChromaDex® Corp. 5
Gamma Glutamyl Transferase reagent is used for the quantitative determination of Gamma -GT in human serum....
For the quantitative kinetic determination of amylase activity, using manual or automated procedures, in human serum and urine....
For quantitative determination of amylase in human serum....
g-GT Liquid Reagent (Kinetic Method). Wavelength: 405 nm. Linear range: 0-200 U/mL. Prepare Working Reagent in the ratio of 5 parts R1 to 1 part of R2, (i.e., 50 mL R1 and 10 mL R2)....
Medicine Products: